title: Phospholamban reduces cardiac Ca-ATPase sensitivity to thapsigargin and cyclopiazonic acid.
authors.affiliation: Department of Biochemistry, West Virginia University School of Medicine, Morgantown, WV, 26506-9142, USA. jmahaney@wvu.edu
authors.forename: J
authors.initials: J
authors.lastname: Mahaney
authors.forename: A
authors.initials: A
authors.lastname: Barlow
authors.forename: B
authors.initials: B
authors.lastname: Honaker
authors.forename: J
authors.initials: J
authors.lastname: Huffman
authors.forename: T
authors.initials: T
authors.lastname: Muchnok
mesh_terms: D019943:Amino Acid Substitution; D000818:Animals; D000911:Antibodies, Monoclonal / Q000276:immunology; D001665:Binding Sites; D002118:Calcium / Q000037:antagonists & inhibitors / Q000378:metabolism; D002135:Calcium-Binding Proteins / Q000235:genetics / Q000276:immunology / Q000378:metabolism*; D000252:Calcium-Transporting ATPases / Q000037:antagonists & inhibitors* / Q000737:chemistry / Q000235:genetics / Q000378:metabolism*; D002460:Cell Line; D004285:Dogs; D004789:Enzyme Activation; D004795:Enzyme Stability; D007211:Indoles / Q000037:antagonists & inhibitors* / Q000494:pharmacology; D007527:Isoenzymes / Q000037:antagonists & inhibitors / Q000737:chemistry / Q000235:genetics / Q000378:metabolism; D007700:Kinetics; D008861:Microsomes / Q000187:drug effects / Q000201:enzymology / Q000378:metabolism; D009206:Myocardium / Q000201:enzymology* / Q000378:metabolism; D011487:Protein Conformation; D012519:Sarcoplasmic Reticulum / Q000187:drug effects / Q000201:enzymology / Q000378:metabolism; D018411:Spodoptera; D019284:Thapsigargin / Q000037:antagonists & inhibitors* / Q000494:pharmacology; D000099211:Phospholamban
chemical_list: D000911:Antibodies, Monoclonal; D002118:Calcium; D002135:Calcium-Binding Proteins; D000252:Calcium-Transporting ATPases; D007211:Indoles; D007527:Isoenzymes; D019284:Thapsigargin; D000099211:Phospholamban; C000543:cyclopiazonic acid